Active ingredientFlavoxateCat. No. P-F054-001CAS 15301-69-6Family · Pharmaceutical analytical standards
Flavoxate
A urinary antispasmodic approved in the United States in 1970: it relaxes the smooth muscle of the bladder and relieves urgency, burning and frequent urination in cystitis, prostatitis and urethritis, without treating the infection itself. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?Its molecule is built on a flavone skeleton (it is a 3-methylflavone derivative), the same basic structure as flavonoids, the pigments of many flowers and fruits.
Go to the active ingredient →Active ingredientFlavoxateCat. No. P-F054-001CAS 15301-69-6
Active ingredientFlavoxate HydrochlorideCat. No. P-F054-002CAS 3717-88-2
Pharmacopoeial impurityFlavoxate EP Impurity ACat. No. P-F054-003CAS 3468-01-7
Pharmacopoeial impurityFlavoxate Hydrochloride EP Impurity BCat. No. P-F054-004CAS 35888-94-9
Pharmacopoeial impurityFlavoxate Hydrochloride EP Impurity CCat. No. P-F054-005CAS 1286165-14-7
Pharmacopoeial impurityFlavoxate USP Related Compound BCat. No. P-F054-006CAS 90101-87-4
Isotopically labelledFlavoxate EP Impurity A-d5Cat. No. P-F054-007CAS 1189883-79-1
Isotopically labelledFlavoxate-d4Cat. No. P-F054-008CAS 1189805-21-7
Isotopically labelledFlavoxate-d5Cat. No. P-F054-009CAS 2748541-85-5
ImpurityFlavoxate Impurity 1Cat. No. P-F054-010CAS 91830-42-1
ImpurityFlavoxate N-Oxide HydrochlorideCat. No. P-F054-011CAS 2732347-10-1
ImpurityMethyl 2-hydroxy-3-propionylbenzoateCat. No. P-F054-012CAS 88466-30-2
ImpurityFlavoxate Impurity 2Cat. No. P-F054-013CAS 91849-09-1No product matches your search.
EDQM standards 3
The official European Pharmacopoeia standards for this family.
Reference substanceFlavoxate hydrochloride CRSEDQM code Y0000736Family FlavoxateImpurityFlavoxate impurity A CRSEDQM code Y0000737Family FlavoxateImpurityFlavoxate impurity B CRSEDQM code Y0000738Family FlavoxateNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.